FIELD: medicine, ophthalmology.
SUBSTANCE: before blood sampling a patient should be kept for 45 min under darkness conditions with opened eyes. Blood sampling at the quantity of 40.0-60.0 ml should be performed under conditions of normal illumination, at availability of dark bandage at patient's eyes. Autoblood should be introduced parenterally in 20 min, not earlier, after bandage removal once daily. Course consists of about 7-12 introductions for 2-3 wk. The method provides higher activity of Mjuller's cells, normalization of functional activity in photoreceptors and , thus, the decrease of light threshold of distinction.
EFFECT: higher efficiency.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR IMPROVING VISION FUNCTION IN PATIENTS SUFFERING FROM VASCULAR AND DYSTROPHIC EYE FUNDUS DISEASES | 2004 |
|
RU2291698C2 |
METHOD OF PREVENTION AND TREATMENT OF RETINOPATHY IN DYSMATURE INFANTS | 2008 |
|
RU2387416C1 |
METHOD FOR TREATING RETINAL VASCULAR DISEASES ACCOMPANIED WITH HYPOCOAGULATION, HEMORRHAGIC SYNDROME AND SEROTONIN INSUFFICIENCY | 2003 |
|
RU2244529C1 |
AGENT RECOVERING RETINA EYE FUNCTION | 1993 |
|
RU2073518C1 |
TETRAPEPTIDE STIMULATING EYE RETINA FUNCTION, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USING | 2000 |
|
RU2161982C1 |
SURGERY TECHNIQUE FOR SUBRETINAL HAEMORRHAGES COMBINED WITH AGE-SPECIFIC MACULAR DYSTROPHY WITH SUBRETINAL NEOVASCULAR MEMBRANE | 2008 |
|
RU2366388C1 |
METHOD OF SURGICAL TREATMENT OF NON-EXSUDATIVE FORM OF CENTRAL CHORIORETINAL DYSTROPHY OF RETINA | 2017 |
|
RU2649569C1 |
METHOD OF SURGICAL TREATMENT OF THE CICATRICAL STAGE OF THE SUBRETINAL NEOVASCULAR MEMBRANE | 2017 |
|
RU2647803C1 |
METHOD OF TREATING CHRONIC ISCHEMIC RETINOPATHY | 2018 |
|
RU2675021C1 |
METHOD FOR EXAMINING CENTRAL REGION OF POSTERIOR EYE SEGMENT | 2006 |
|
RU2319448C2 |
Authors
Dates
2005-08-20—Published
2003-11-03—Filed